Increased click here levels of TGF-β expression contribute to the enhanced suppressor function of CD62LhiFoxP3+Tregs versus CD62LloFoxP3+Tregs 7. CD62LloFoxP3+Tregs are thought to reflect an activated phenotype characterized by increased cycling 21–23. Importantly, our group and others have previously shown that the frequency of suppressive CD62LhiFoxP3+Tregs decline with age in NOD female mice which corresponds with the progression of β-cell autoimmunity 7, 24. The critical events that induce and maintain the frequency of CD62LhiFoxP3+Tregs, however, are poorly understood. Recent studies have demonstrated that IL-2 plays a key role in the maintenance

of FoxP3+Tregs homeostasis 25, 26. Mice lacking or having reduced expression of the Il2 gene develop severe, systemic autoimmunity due to the reduction of FoxP3+Tregs 27, 28. Furthermore, Sakaguchi and co-workers showed that diabetes is exacerbated in NOD mice when treated with a neutralizing Ab specific for IL-2 at an early age 29. Also, IL-2 in combination with TGF-β is important

for the differentiation of naïve CD4+ T cells into adaptive FoxP3+Tregs in vitro 30, 31. More than 20 GDC 0199 chromosomal loci, termed insulin-dependent diabetes (Idd) regions, are associated with T1D susceptibility and resistance 32, 33. While no one gene is sufficient for the development of diabetes, the combined effects of susceptibility genes influence the progression of β-cell autoimmunity 32, 33. NOD mice congenic for the Idd3 locus derived from diabetes-resistant mouse strains exhibit a reduced incidence and delayed onset of T1D 34–37. Idd3 contains genes encoding immunoregulatory molecules including IL-2 and IL-21 34–37. The NOD Idd3 locus has been associated with reduced IL-2 expression by T cells and an aberrant FoxP3+Tregs pool 37, 38. These findings suggest that T1D is influenced by dysregulation of IL-2 expression, which leads to reduced

FoxP3+Tregs frequency and/or function found in NOD mice. In the current study, NOD mice congenic for a resistant Idd3 interval derived from C57BL/6 mice (NOD.B6Idd3) were used to further define the role of IL-2 in regulating the peripheral FoxP3+Tregs pool. We present evidence that reduced IL-2 expression Celecoxib leads to temporal dysregulation of the ratio between suppressor-deficient CD62LloFoxP3+Tregs and suppressor-competent CD62LhiFoxP3+Tregs, resulting in a pool of FoxP3+Tregs insufficient to regulate β-cell autoimmunity. Studies have demonstrated that Idd3 in NOD mice contributes to the progression of β-cell autoimmunity by influencing the pool of FoxP3+Tregs 37, 38. To further study the effect(s) of Idd3 on FoxP3+Tregs, NOD.B6Idd3 mice congenic for an ∼17 Mb interval derived from the c57a/b genotype were employed (Supporting Information Table 1). This line of NOD.

107), ALT (p = 0.925), serum albumin (p = 0.212) between CX 5461 4 groups, platelet count was significantly decreased along with the extension of cysts volume (p = 0.030). Overall, mean FANLTC score and FACT-Hep were 71.8 ± 12.5, and

32.4 ± 5.8, respectively. FANLTC (p = 0.017) and FACT-Hep (p = 0.003) were significantly decreased with the increasing cyst volume. Conclusion: In this cross-sectional report, we could clear the relationship between liver cyst volume and QOL in ADPKD patients. We will show the long-term influence on QOL in this ongoing prospective longitudinal study. SYUKRI MAIMUN1, SJA’BANI MOCHAMMAD2, SOESATYO MARSETYAWAN HNE3, ASTUTI INDWIANI4 1Department of Internal Medicine, School of Medicine, Syiah Kuala University, Banda Aceh, Indonesia; 2Department of Internal Medicine, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia 3; 3Department of Histology and Cell Biology, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia; 4Department of Pharmacology, Faculty RAD001 of Medicine, Gadjah Mada University, Yogyakarta, Indonesia Introduction: Recurrent urinary tract infection (UTI) is common among young women and one of its risk factors is a genetic factor. Polymorphisms in promoter region (G-800A (rs1800468) and C-509T (rs1800469)) of transforming growth factor-β1 (TGF-β1), gene play a pivotal role in several infectious diseases but the association of these polymorphisms with recurrent UTI SPTLC1 is still

unavailable. The correlation of TGF-β1 G-800A and C-509T polymorphisms with recurrent UTI young women was assessed in this study. Methods: This study was conducted with case-control study, TGF-β1 G-800A and C-509T polymorphisms among 34 recurrent UTI patients and 34 healthy subjects, that were aged 15–50 years old, adjusted

in 5 year differences, were evaluated with polymerase chain reaction – restriction fragment length polymorphism (PCR-RFLP) and confirmed by DNA sequencing. All of the subjects were collected in the same hospital and diagnosed in the same day as in the clinic. This study was conducted with the approval of the Ethics Committee of School of Medicine, Syiah Kuala University, Banda Aceh, Indonesia. The subject recruitment and sample collection were done only after obtaining written informed consent of the participants. Results: At position −800 genotypes and allele frequencies showed no significant differences between recurrent UTI patients (GG 97.1%; GA 2.9%; AA 0%) and normal control (GG 97%; GA 0%; AA 2.9%) young women. Dominant and recessive models analysis also did not find significant correlation between recurrent UTI patients and normal control young women. At -509 position, genotypes and allele frequencies showed no significant differences between recurrent UTI patients (CC 20.6%; CT 61.8%; TT 17.7%) and control individuals (CC 2.9%; CT 73.6%; TT 23.5%). However, a significant correlation were found in this study in dominant model analysis (p = 0.027).

The heavy burden of cardiovascular disease and diabetes was assessed by Snyder et al.25 who compared awareness, treatment and control of hypertension, elevated low-density lipoprotein (LDL) cholesterol and diabetes in non-CKD and CKD populations. Dividing the CKD population by cardiovascular disease status and CKD stage, they showed that likelihood of hypertension was 5 times higher for stage 1–2 CKD patients than for non-CKD counterparts, and 1.4–2.5 times higher for stages 3–4. Among people with hypertension, awareness of the condition was 40% lower for those with stage 1–2 CKD compared with the non-CKD population, and treatment of defined hypertension was also 40% lower. For stage 1–2 CKD patients, hypertension

was controlled (defined as blood pressure <140/90 mmHg) for only one in five, and control was 50% lower for stage 3–4 CKD patients compared with the non-CKD population. Use of kidney-protective Selleckchem SB525334 medications (angiotensin-converting enzyme inhibitors and angiotensin receptor blocking agents) was half as likely among stage 1–2 CKD patients and 20% less likely among stage 3–4 CKD Vemurafenib datasheet patients than in the non-CKD population. These observations from the US National Health and Nutrition Examination Survey (NHANES) random population sample suggest that CKD patients receive inadequate hypertension care, and are thus at risk for the observed high cardiovascular event rates.14,15 Awareness,

treatment and control of hypercholesterolaemia is also poor in the CKD population.

Rates of LDL cholesterol above 100 mg/dL are highest for stage 3–4 CKD patients, who also have the lowest awareness and lowest odds of treatment, and only 14% achieve control (LDL cholesterol less than 100 mg/dL). These patients are thus predisposed to higher risk of cardiovascular events, which increase exactly when hypercholesterolaemia treatment and control are lowest. These observations support consideration of early and comprehensive identification and intervention strategies, with MRIP treatment guidelines comparable to the general population,26 until such time as clinical trial results exist to guide therapy. Further, glycaemic control in the CKD population with diabetes was lowest in stage 1–2 CKD compared with non-CKD counterparts. Additional surveillance data show that only 60% of the Medicare population with diagnosed diabetes receives two annual HbA1c tests to monitor glycaemic control. This percentage is even lower in Taiwan, a population with the highest ESRD incidence in the world.27 Only one in five diabetic patients in the USA receives screening for kidney disease with at least one microalbuminuria test per year, as do only 40% of diabetic patients in Taiwan. These numbers provide further evidence of less-than-needed care for this high-risk population. Several investigators report on CKD risk factors from the NHANES random population sample and other community databases.

In apparent contrast, results from immunization studies with the hapten (4-hydroxy-3-nitrophenyl) acetyl suggested a stochastic model, in which a particular B cell is recruited equally to develop into either extrafollicular or germinal center responses 25, 26. It is difficult to analyze B-cell fate decisions in vivo due selleck products to the lack of known unique characteristics of B cells that give rise to extrafollicular foci and germinal centers, respectively. Our aim was to establish a system with which to follow the contributions of a naturally occurring, antigen-specific B-cell

population to help elucidate early B-cell selection events following influenza virus infection. Earlier immunization studies with influenza A/Puerto Rico/34/8 (A/PR8) revealed a particularly strong, virus neutralizing and protective 2 early-induced response encoded by the C12 idiotype (C12Id) to one of the four major antigenic sites on HA1, the Cb site, in BALB/c mice 27. Following immunization these C12Id+ HA-specific Ab were shown to dominate the early HA-specific serum IgG response, but were absent from secondary responses 24, 27. In contrast to another extensively studied idiotype-restricted response (C4) specific for the antigenic

site Sb, which showed extensive mutations following immunization with influenza A/PR8 28–31, sequence analysis of over 50 HA-specific hybridomas generated following primary immunization indicated PF-02341066 purchase oxyclozanide that C12Id+ Ab are exclusively germline

encoded 27. C12Id Ab utilize a single Vκ-gene (Vk4/5–VkC12), together with one of two closely related VH-genes from the J558 family (VHC12.1 and VHC12.2). In contrast to their similar V-gene usage, these Ab use any of the four Jk and JH genes, respectively and at least three distinct D genes. Thus, HA-specific C12Id+ Ab are diverse in CDR3 region lengths and sequence, while sharing fine specificity for the Cb site 27. Using labeled influenza A/PR8 HA 32 and a mAb to C12Id 24 we followed C12Id+ HA-specific B cells in the context of the polyclonal B-cell response to influenza virus infection in WT mice. The current study identifies HA-specific C12Id+ B cells as conventional follicular B cells that initiate both extra- and intra-follicular B-cell responses, although with a strong bias toward the extrafollicular response type. This bias was not overcome with increased availability of T-cell help, suggesting that infection-induced innate signals might drive the preponderance of extrafollicular responses during early infection.

All cells were cultured in a final volume of 200 µl in the presence of 1 × 104 irradiated peripheral mononuclear cells as antigen-presenting cells. All tests were conducted in triplicate. Cell cultures were then incubated at 37°C for 4 days and supernatants were obtained for cytokine measurements before HSP assay being pulsed with 1 µCi [3H]-thymidine per well for the final 18 h of incubation. Plates were harvested onto nylon filters using the Betaplate system and radioactivity was quantified using a Betaplate counter. Results are expressed in counts per minute (cpm) as the mean of triplicate cultures ± standard error of the mean (s.e.m.).

Percentage suppression was calculated using the formula: (1−cpm in presence of Treg cells/cpm in the absence of Treg cells) × 100. Conventional (CD4+CD25-) and Treg (CD4+CD25high) populations were isolated from tumour samples by flow cytometry cell sorting and stimulated with the irradiated autologous CD3- fraction, containing tumour cells and tumour-associated antigen-presenting cells (APCs), in the presence or absence of IL-2 (50 ng/ml) for 10 days. Cultures were then stimulated with phorbol

myristate SAR245409 in vivo acetate (PMA)/ionomycin and stained with anti-CD4 and anti-IL-17 mAb. The supernatants were diluted for measurement of cytokine concentration by enzyme-linked immunosorbent assay (ELISA) (R&D kits, Minneapolis, MN, USA). Briefly, microtitre plates precoated with capturing mAbs were blocked with 2% bovine serum albumin (BSA)/PBS. After washing, samples and controls Quinapyramine were added at 50 µl per well and incubated for 2 h with a biotinylated detecting antibody (50 µl per well) in 2% BSA/PBS/Tween-20. Plates were

washed and incubated for 30 min with streptavidin-conjugated horseradish peroxidase. Next, 100 µl of 0·0125% tetramethylbenzidine and 0·008% H2O2 in citrate buffer was used as substrate. A standard curve was performed for each plate and used to calculate the absolute concentrations of cytokines. Normally distributed data sets were analysed by Student’s t-test, paired t-test, analysis of variance (anova) and linear regression and correlation analysis (using ‘Primer for Biostatistics’). The Wilcoxon two-sample test and Kruskall–Wallis test were used for data sets that were not normally distributed (using sas). P ≤ 0·05 was considered significant. Although the high frequency of Th17 cells has been shown to correlate with favourable outcome in patients with several types of cancer, their distribution is unclear as yet in human bladder tumours. Those prompted us to assess the presence of Th17 cells in the peripheral blood and tumours tissue of patients with bladder carcinoma. PBMCs in patients with bladder carcinoma (n = 45) and in healthy controls (n = 20) were examined for the prevalence of Th17 cells.

[14] Recently, functional neuroimaging suggested that the bladder is under tonic influence of the brain.[15, 16] Parkinson’s disease and stroke are one of the major neurologic disorders, and they also cause bladder dysfunction.[17, 18] Although the frequency of bladder dysfunction in depression is lower (up to 25.9%) than that in Parkinson’s disease (up to 75%) and stroke (up to 55%), it is significantly higher than that in age-matched

controls (10%).[17-19] Therefore, depression/anxiety find more can be regarded as an important cause of bladder dysfunction, although the detailed mechanism of the causation remains unclear. In this review, we performed a systematic review of the literature to identify the frequency, lower urinary tract symptoms, urodynamic findings, putative underlying pathology, and management of bladder dysfunction in patients with PI3K phosphorylation depression/anxiety. Although lower urinary tract symptoms (LUTS) have been described in major depression,[6-8] ,[11-13], [20] it is difficult to determine to what extent depression is a contributing factor. Lower urinary tract symptoms are common in the general population.[21] Men aged 60 or older may have benign prostatic hyperplasia.[22] Women may have physical stress-induced urinary incontinence. In addition, neurologic diseases might contribute to LUTS. For instance, OAB occurs in persons older than 65 due, in part, to latent

brain ischemia.[23] Peripheral factors for LUTS include metabolic syndrome, diabetes, dyslipidemia, hypertension, and smoking, all of which are relevant to atherosclerosis.[24, 25] To overcome these problems, patient recruitment with no selective bias, together with community-based control subjects, is needed. In a recent study by Ito et al.[19] 224 depressive patients (97 men and 127 women, aged 42 [14–80] years, Oxymatrine illness duration 2.2 years [1 week to 40 years], all visiting a university psychiatry clinic) and 391 healthy control subjects (271 men and 120 women, age

48 [30–69] years, all undergoing an annual health survey) were recruited. The 224 depressive patients were subdivided into 128 patients who had not received any medication (drug-naïve group; 61 men, 67 women; age 40.3 [14–80] years, illness duration 1.7 [1 week to 40 years] years), and 96 patients who were referred from primary care physicians and had already received medication (medicated group; 36 men, 60 women; age 43.5 [15–79] years; illness duration 2.8 [1 week to 15 years] years). The results of the study showed that the LUTS questionnaire scores of the drug-naïve depression group (up to 25.9%) were significantly higher (P < 0.01, 0.05) than that in the control group around 10% (Fig. 1) (medicated group appears later). The majority of the depressive patients experienced the onset of LUTS at around the same time, either with or after the appearance of an affective disorder. None had a history of pelvic organ surgery, or symptoms of neurologic disorder such as stroke, Parkinson’s disease or diabetes.

Because FACS- and PCR-based analyses examine T-cell clonality from different aspects, the future development of tetramer-based FACS on Leishmania Ag-specific CD4+ T cells would be helpful for accurate assessment.

Nevertheless, results from these studies clearly indicate the magnitude of CD4+ T-cell activation induced by different Leishmania species correlates with infection outcome. Having demonstrated strong T-cell activation and IFN-γ production in Lb infection, we then examined whether pre-infection with Lb could provide cross-protection against secondary La infection via an enhanced T-cell activation. We showed that this cross-protection correlated nicely with the increased T-cell activation and IFN-γ production from CD4+ T cells (Figure 3), a finding consistent with previous studies on L. major Selumetinib pre-infection followed with a secondary infection with La or L. mexicana parasites (24,32). Again, the tested 4 Vβ subset contributed selleck compound comparably to IFN-γ production. Because the quality or multifunctional

capacity of CD4+ T cells is a crucial determinant in vaccine-mediated protection against L. major (33) and malaria (34), we investigated the production of several cytokines from CD4+ CD44+ effector T cells in La- or Lb-infected mice. It was evident that CD4+ CD44+ T cells derived from Lb-infected mice tended to produce high levels of IFN-γ, but low levels of IL-10 and IL-17 (Figure 5a), and that this Th1-favoured response was maintained even when cells were stimulated in vitro with La antigen (Figure 5b). Therefore, the healing from from control of Leishmania infection requires sequential events that include efficient dendritic cell activation (5), adequate innate responses (12) and activated Th1-type responses to a relatively broad spectrum of parasite antigens. Notably, the adoptive

transfer of Lb-specific CD4+ T cells into naïve mice failed to protect mice against the subsequent La infection (data not shown), a finding consistent with a previous report showing the lack of protection against L. mexicana infection following the adoptive transfer of L. major-specific CD3+ T cells (24). The reasons for this lack of cross-protection by cell transfer alone may include the maintenance of effective Th1 responses and cell recruitment in the recipients, as well as the unique features of L. amazonensis and L. mexicana parasites (35). In summary, our comparative analyses of CD4+ T cells in different models of cutaneous leishmaniasis indicate that Leishmania infection does not change the diversity of the TCR Vβ repertoire in either self-healing or nonhealing model and that multiple TCR Vβ CD4+ T cells contribute collectively and comparably to IFN-γ production.

1b). The lungs were washed by cannulating the AZD4547 research buy trachea and gently injecting/recovering (3×) 1·0 ml of PBS. The bronchoalveolar lavage fluid (BAL) was centrifuged at 300 g at 4°C for 5 min and the supernatants were stored at −20°C for cytokine analysis. The cell pellet was resuspended in 0·1 ml of 3% bovine serum albumin (BSA) and cells counted using a haemocytometer. The cells were then cytocentrifuged and stained with haematoxylin and eosin (H&E) for differential

counting based on cell morphology and staining patterns. The means of three independent counts of 100 cells in a randomized field were shown. Following bronchoalveolar lavage, the lungs were fixed with formalin. Serial sagittal sections of whole lung (3–4 µm Nutlin-3 mw thick) were cut and stained with Gomori trichome for light microscopy. At least 10 fields were selected randomly and examined. The severity of the inflammatory process in the lungs was scored by two pathologists who were blinded to group identity. The scale varied from 0 to 5 as follows: 0, no inflammation, 1, minimal; 2, mild; 3,

medium; 4, moderate; and 5, marked [35,36]. The EPO assay was performed as described previously [37]. Briefly, a 100-mg sample of tissue from each lung was homogenized in 1·9 ml of PBS and centrifuged at 12 000 g for 10 min. The supernatant was discarded and the erythrocytes were lysed. The samples were centrifuged, the supernatant discarded and the pellet resuspended in 1·9 ml of 0·5% hexadecyltrimethyl ammonium bromide in PBS saline. The samples were frozen in liquid nitrogen and centrifuged at 4°C at 12 000 g for 10 min. The supernatant was used for the enzymatic assay. Briefly, o-phenylenediamine (OPD) (10 mg) Suplatast tosilate was dissolved in 5·5 ml distilled water, and then 1·5 ml of OPD solution was added to 8·5 ml of Tris buffer (pH 8·0), followed by addition of 7·5 µl H2O2. In a 96-well plate, 100 µl of substrate solution was added to 50 µl of each sample. After 30 min, the reaction was stopped with 50 µl of 1 M H2SO4 and the absorbance was read at 492 nm. Levels of IL-4, IL-5,

IL-10, TNF-α and IFN-γ were determined by bronchoalveolar lavage (BAL) of the different groups of mice with an enzyme-linked immunosorbent assay (ELISA) sandwich technique using commercially available kits (OptEIA; BD Bioscience, San Jose, CA, USA), according to the manufacturer’s protocol. The optical density (OD) values were read at 450 nm. The results were expressed as picograms per millilitre, compared to a standard curve. The levels of OVA-specific IgE in serum were determined by ELISA, as described previously [38,39]. Briefly, Maxisorp 96-well microtitre plates (nunc, Roskilde, Denmark) were coated with rat anti-mouse unlabelled IgE (1 : 250; Southern Biotechnology, AL, USA) in pH 9·6 carbonate-bicarbonate buffer for 12–16 h at 4°C and then blocked for 1 h at room temperature with 200 µl/well of 0·25% PBS-casein.

Synthesis of cDNA was performed using Superscript® III Reverse Transcriptase (Invitrogen) according to the manufacturer’s protocol. IgE and IgG heavy chain gene rearrangements were then amplified using an isotype-specific PCR. PCR amplification was performed with 100–200 ng cDNA or aliquots of the PCR1 product as templates, 0.2 μm of each primer, 200 μm of each dNTP, 1.25 units PFU polymerase (Promega, Madison, WI, USA) and a buffer supplied by the manufacturer. Details of the primers used are shown in Table 1. Specific primers

for the three large IGHV gene families (VH1F, VH3F and VH4F) were used as forward primers in separate reactions. IgG1 and IgG2 were amplified by standard PCR using appropriate isotype specific primers (G1 and G2/G4IN) as reverse Dinaciclib primers. Reactions times for this PCR were 95 °C for 3 min, followed by 35 cycles of

95 °C for 30 s, 61 °C Ferroptosis phosphorylation for 30 s, 72 °C for 4 min and then a final extension at 72 °C for 5 min. Semi-nested PCR were used for IgG3 (reverse primers: G3OUT and G3IN), IgG4 (G4OUT and G2/G4IN) and IgE (IGEOUT and IGEIN) sequence amplifications. PCR1 conditions used were initial denaturation at 95 °C for 3 min, followed by 35 cycles of 95 °C for 30 s, 60 °C for 30 s, 72 °C for 4 min and a final extension at 72 °C for 5 min. For PCR2, the only changed condition from those of PCR1 was the annealing temperature, which was 65 °C for IgE and IgG4, and 61.7 °C for IgG3. PCR2 was run for 25 Endonuclease cycles. All PCR were run on a Tpersonal 48 cycler (Biometra, Gottingen, Germany). PCR products were then cloned and sequenced at the Ramaciotti Centre for Gene Function Analysis, University of New South Wales, as previously described [13]. Bioinformatic analysis.  Rearranged VDJ sequences were aligned against the germline repertoire using the iHMMune-align program [19] and the UNSWIg repertoire of germline genes [20] (http://www.ihmmune.unsw.edu.au/unswig.html). This repertoire was updated with a number of IGHV polymorphisms that we have identified

in the PNG population and have submitted to GenBank (accession numbers HM855272–HM855948), as well as putative polymorphisms that have been identified in previous studies [20, 21]. Evidence in support of the existence of these putative polymorphisms within rearranged VDJ genes can be found at http://cgi.cse.unsw.edu.au/~ihmmune/IgPdb/. The number of mismatches between the germline IGHV genes and each rearranged sequence was noted. Sequences with more than 45 mismatches were removed from the data set because of the likelihood they included sequencing errors. Clonally related sequences were identified on the basis of shared IGHV, IGHD and IGHJ genes, as well as shared N regions and shared point mutations.

Interestingly, we also noted TGF-β secretion, which was lost in A2aR KO mice, suggesting that TGF-β may be produced by iNKT cells and enhanced through adenosine stimulating A2aR. However, TGF-β production has not been described in iNKT cells and could have been indirectly from other cells. We therefore activated sorted iNKT cells with

plate-bound CD1d molecules and assessed their TGF-β production. As Fig. 3B shows, iNKT cells directly produced TGF-β in the active form in response to CD1d-mediated activation. To further confirm Ibrutinib cost that the cytokines observed in sera were from NKT cells, we injected WT and A2aR KO mice with α-GalCer and tested NKT and NK cells for their intracellular cytokine content. NKT cells from A2aR KO mice produced significantly more IFN-γ compared to stimulated WT counterparts. Additionally, NK cells known to be transactivated by NKT cells produced significantly more IFN-γ in the absence of an A2aR (Fig. 3C, bottom), however, no IL-4 could be detected in these cells (data not shown). Supporting the serum data

(Fig. 3A), we observed a clear trend to a lower IL-4 production in A2aR−/− NKT cells, although not reaching statistical significance (n=3). Collectively, our data suggest that the secretion of type-2 cytokines IL-4, IL-10 and NVP-BKM120 ic50 TGF-β by iNKT cells requires signaling through the A2aR since blocking or genetic ablation of this receptor efficiently abrogates Org 27569 their secretion. In contrast, ligation of the same receptor abrogates the production of IFN-γ. Pharmacological ligation of the high-affinity A2aR might reflect the situation in vivo with low

adenosine concentrations skewing the cytokine production of iNKT cells toward a Th2-type phenotype. Increased levels of adenosine, such as found in tumors might then additionally ligate the low-affinity A2bR and thus inhibit the activation of iNKT cells, comparable to other cell types. Conceivably, the manipulation of the A2aR on iNKT cells might control their activation and support host defense and immunotherapeutic approaches in both malignancy and tolerance. C57BL/6J were purchased from Jackson Laboratories (Bar Harbor, MA, USA). Mice deficient the A2aR were previously described and backcrossed to C57BL/6 background 8. Mice were housed under specific pathogen-free conditions. Animal experiments were performed in accordance to protocols approved by Institutional Animal Care and Use Committee. Six- to eight-week-old C57BL/6J mice were used for experiments. PBS57-loaded or empty CD1d monomers and tetramers were provided by the NIH tetramer facility (Emory Vaccine Center, Atlanta, GA, USA). CADO, CGS21680, and ZM241485 were purchased from Tocris (Ellisville, MO, USA). Cells were cultured in RPMI-1640 supplemented with penicillin, streptomycin (Mediatech, Manassas, VA, USA) and 5% FBS (Hyclone, Logan, UT, USA). DC were generated from mouse BM in the presence of GM-CSF as described in 25 with modifications.